
|

| |
Track this Pro and follow
their portfolio moves with tickerspy™ alerts |
 |
|
 | Baker Bros. Advisors |
| |
Performance |
|
|
|
Similar Pro Portfolios |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
+0.7%
-1.4%
+2.6%
+178.3%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-0.1%
-3.9%
+3.3%
+160.5%
|
Data since: Jul-1-2007 Current Portfolio: Q1 2013
|
|
|
|
|
|
|
|
|
Share this Pro on Facebook
Share this Pro on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| ACAD |
$18.43 |
-0.49 |
-2.59% |
3,492,057 |
93% |
$1.3B |
- |
1198% |
-8% |
+133.3% |
$124.0M | 15.6M shares - No Change
1 Alert (0 News) - View
|
|
|
| AEGR |
$63.70 |
+1.36 |
+2.18% |
934,286 |
119% |
$1.7B |
- |
395% |
-16% |
+63.2% |
$34.8M | 863.7K shares - increase of 249.3K shares
No Alerts/News
|
|
|
| ARIA |
$17.79 |
-0.03 |
-0.14% |
814,767 |
26% |
$3.2B |
- |
16% |
-30% |
-2.8% |
$38.9M | 2.1M shares - increase of 20.9K shares
No Alerts/News
|
|
|
| AUXL |
$17.34 |
+0.10 |
+0.58% |
588,146 |
72% |
$850.0M |
- |
25% |
-41% |
+2.1% |
$36.5M | 2.1M shares - decrease of 2.3M shares
No Alerts/News
|
|
|
| BMRN |
$58.31 |
+0.14 |
+0.24% |
835,824 |
49% |
$8.0B |
- |
62% |
-19% |
-5.3% |
$48.8M | 783.3K shares - increase of 582.9K shares
No Alerts/News
|
|
|
| CERS |
$4.55 |
0.00 |
0.00% |
487,980 |
98% |
$317.2M |
- |
70% |
-18% |
+4.6% |
$28.9M | 6.5M shares - increase of 4.4M shares
No Alerts/News
|
|
|
| CLVS |
$66.06 |
-2.94 |
-4.25% |
369,582 |
69% |
$1.8B |
- |
490% |
-23% |
+141.4% |
$28.7M | 1.0M shares - decrease of 114.0K shares
3 Alerts (0 News) - View
|
|
|
| GEVA |
$41.56 |
-0.72 |
-1.70% |
106,723 |
102% |
$1.1B |
- |
14% |
-28% |
-22.8% |
$506.5M | 9.2M shares - increase of 859.7K shares
No Alerts/News
|
|
|
| GHDX |
$34.05 |
+1.08 |
+3.28% |
471,173 |
165% |
$996.2M |
- |
35% |
-13% |
+21.7% |
$355.7M | 12.6M shares - increase of 217.4K shares
No Alerts/News
|
|
|
| INCY |
$21.41 |
+0.35 |
+1.66% |
1,232,711 |
106% |
$2.8B |
- |
39% |
-19% |
-6.9% |
$346.7M | 14.8M shares - No Change
1 Alert (0 News) - View
|
|
|
| INFI |
$19.46 |
+2.29 |
+13.34% |
5,041,558 |
193% |
$821.2M |
- |
77% |
-61% |
-60.7% |
$57.1M | 1.2M shares - No Change
2 Alerts (0 News) - View
|
|
|
| PCYC |
$88.26 |
+1.07 |
+1.23% |
340,476 |
47% |
$6.3B |
- |
117% |
-8% |
+10.8% |
$878.4M | 10.9M shares - decrease of 520.5K shares
No Alerts/News
|
|
|
| RPRX |
$19.19 |
+1.26 |
+7.03% |
717,496 |
206% |
$334.2M |
- |
149% |
-8% |
+24.7% |
$36.4M | 2.3M shares - increase of 763.1K shares
3 Alerts (1 News) - View
|
|
|
| SGEN |
$32.20 |
+0.22 |
+0.69% |
472,949 |
65% |
$3.8B |
- |
53% |
-17% |
-7.6% |
$686.1M | 19.3M shares - No Change
No Alerts/News
|
|
|
| VPHM |
$28.69 |
-0.18 |
-0.62% |
1,648,255 |
237% |
$1.8B |
- |
47% |
-9% |
+15.8% |
$214.6M | 8.5M shares - decrease of 496.7K shares
No Alerts/News
|
|
|
|
|
Discuss Baker Bros. Advisors's portfolio
|
|
|
|
| |

|
| |
|
| |

|
| |
Repros Therapeutics Inc.(R) Announces Proposed Public Offering of Common Stock RPRX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 17, 04:13PM from (globenewswire.com) THE WOODLANDS, Texas, June 17, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (Nasdaq:RPRX) today announced that it has
Flag
Post a comment
Short Interest Falls in Vertex, Rises in Biogen Idec BMY PFE MRK AMGN CELG REGN BIIB VRTX VVUS GILD ALXN PCYC ONXX ARNA DNDN ILMN NVS
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 12, 01:29PM from (www.benzinga.com) Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB), saw the most significant rise in short interest
Flag
Post a comment
Clovis Oncology Announces Upsizing and Pricing of Public Offering of Common Stock CLVS
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - June 11, 08:02PM from (www.businesswire.com) Clovis Oncology (NASDAQ:CLVS) announced today the pricing of an underwritten public offering of 3,333,334 shares of its common
Flag
Post a comment
PropThink Biotech Stocks with Big Upside Potential CBST RMD BMRN ENDP KERX HSP TSRX STML
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - June 11, 08:10AM from (247wallst.com) The world of biotech investing is always a difficult one. Often a binary event, such as a U.S. Food and Drug Administration
Flag
Post a comment
BioMarin to Present at the Goldman Sachs Global Healthcare Conference BMRN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 06, 09:13AM from (globenewswire.com) SAN RAFAEL, Calif., June 6, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Joshua
Flag
Post a comment
BioMarin Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKU BMRN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 05, 06:13AM from (globenewswire.com) SAN RAFAEL, Calif., June 5, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that it has
Flag
Post a comment
Mid-Day Market Update: Stocks Pare Gains, G-III Apparel Surges On Q1 Results DG GIII ARRY CRM INFI SLCA ET
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 04, 01:24PM from (www.benzinga.com) Midway through trading Tuesday, the Dow traded up 0.01 percent to 15,256.10, while the NASDAQ rose 0.24 percent to 3,473.61.
Flag
Post a comment
This Stock Was Up More Than 100 Percent Monday CLVS
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 04, 08:28AM from (www.benzinga.com) It’s not every day that a stock moves more than 100 percent in a single trading session but one biopharma name printed a double by the end of the trading day Monday.
Flag
Post a comment
Mid-Morning Market Update: Markets Rise, Cracker Barrel Posts Upbeat Earnings MNKD CLP MAA BMRN DSGX CBRL INFI
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 03, 10:34AM from (www.benzinga.com) Following the market opening Monday, the Dow traded up 0.69 percent to 15,220.16, while the NASDAQ rose 0.12 percent to 3,460.18.
Flag
Post a comment
BioMarin to Present at the Jefferies Global Healthcare Conference BMRN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 30, 04:13PM from (globenewswire.com) SAN RAFAEL, Calif., May 30, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Dan
Flag
Post a comment
Vimizim MAA Validated by the EMA BMRN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 30, 07:13AM from (globenewswire.com) SAN RAFAEL, Calif., May 30, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that the
Flag
Post a comment
FDA Accepts Vimizim BLA and Grants Priority Review Designation BMRN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 30, 07:13AM from (globenewswire.com) SAN RAFAEL, Calif., May 30, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that the
Flag
Post a comment
|
|